These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15320751)

  • 1. Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity.
    Romanelli F; Smith KM; Hoven AD
    Curr Pharm Des; 2004; 10(21):2643-8. PubMed ID: 15320751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-HIV-1 activity of chloroquine.
    Savarino A; Gennero L; Sperber K; Boelaert JR
    J Clin Virol; 2001 Feb; 20(3):131-5. PubMed ID: 11166661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of hydroxychloroquine as an antirheumatic drug.
    Fox RI
    Semin Arthritis Rheum; 1993 Oct; 23(2 Suppl 1):82-91. PubMed ID: 8278823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The additive in vitro anti-HIV-1 effect of chloroquine, when combined with zidovudine and hydroxyurea.
    Boelaert JR; Sperber K; Piette J
    Biochem Pharmacol; 2001 Jun; 61(12):1531-5. PubMed ID: 11377382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chloroquine and Hydroxychloroquine Increase Retinal Pigment Epithelial Layer Permeability.
    Korthagen NM; Bastiaans J; van Meurs JC; van Bilsen K; van Hagen PM; Dik WA
    J Biochem Mol Toxicol; 2015 Jul; 29(7):299-304. PubMed ID: 25752684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ability of chloroquine to prevent tat-induced cytokine secretion by monocytes is implicated in its in vivo anti-human immunodeficiency virus type 1 activity.
    Rayne F; Vendeville A; Bonhoure A; Beaumelle B
    J Virol; 2004 Nov; 78(21):12054-7. PubMed ID: 15479845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chloroquine inhibits HIV-1 replication in human peripheral blood lymphocytes.
    Pardridge WM; Yang J; Diagne A
    Immunol Lett; 1998 Nov; 64(1):45-7. PubMed ID: 9865601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine exerts an additive in vitro anti-HIV type 1 effect when associated with didanosine and hydroxyurea.
    Boelaert JR; Sperber K; Piette J
    AIDS Res Hum Retroviruses; 1999 Sep; 15(14):1241-7. PubMed ID: 10505672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lysosomotropic amines, chloroquine and hydroxychloroquine: a potentially novel therapy for graft-versus-host disease.
    Schultz KR; Gilman AL
    Leuk Lymphoma; 1997 Jan; 24(3-4):201-10. PubMed ID: 9156650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New use for old drugs? Prospective targets of chloroquines in cancer therapy.
    Vlahopoulos S; Critselis E; Voutsas IF; Perez SA; Moschovi M; Baxevanis CN; Chrousos GP
    Curr Drug Targets; 2014; 15(9):843-51. PubMed ID: 25023646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells.
    van den Borne BE; Dijkmans BA; de Rooij HH; le Cessie S; Verweij CL
    J Rheumatol; 1997 Jan; 24(1):55-60. PubMed ID: 9002011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes.
    Sperber K; Kalb TH; Stecher VJ; Banerjee R; Mayer L
    AIDS Res Hum Retroviruses; 1993 Jan; 9(1):91-8. PubMed ID: 8427717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological resistance of hydroxychloroquine for Plasmodium vivax malaria in the Republic of Korea.
    Lee SW; Lee M; Lee DD; Kim C; Kim YJ; Kim JY; Green MD; Klein TA; Kim HC; Nettey H; Ko DH; Kim H; Park I
    Am J Trop Med Hyg; 2009 Oct; 81(4):600-4. PubMed ID: 19815873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the antiviral effects of chloroquine.
    Savarino A; Di Trani L; Donatelli I; Cauda R; Cassone A
    Lancet Infect Dis; 2006 Feb; 6(2):67-9. PubMed ID: 16439323
    [No Abstract]   [Full Text] [Related]  

  • 15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chloroquine on reducing HIV-1 replication in vitro and the DC-SIGN mediated transfer of virus to CD4+ T-lymphocytes.
    Naarding MA; Baan E; Pollakis G; Paxton WA
    Retrovirology; 2007 Jan; 4():6. PubMed ID: 17263871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine is much less active than chloroquine against chloroquine-resistant Plasmodium falciparum, in agreement with its physicochemical properties.
    Warhurst DC; Steele JC; Adagu IS; Craig JC; Cullander C
    J Antimicrob Chemother; 2003 Aug; 52(2):188-93. PubMed ID: 12837731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.
    Cruciani M; Mengoli C; Serpelloni G; Parisi SG; Malena M; Bosco O
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD008270. PubMed ID: 23740608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine.
    Stevens DM; Crist RM; Stern ST
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33396545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity.
    Savarino A; Gennero L; Chen HC; Serrano D; Malavasi F; Boelaert JR; Sperber K
    AIDS; 2001 Nov; 15(17):2221-9. PubMed ID: 11698694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.